Smart Drug Delivery Systems Based on DNA Nanotechnology.

Area of Science:

• Biotechnology and Biomedical Engineering
• Nanomedicine
• Materials Science

Background:

• DNA nanotechnology utilizes DNA's programmable nature for creating complex nanostructures.
• These nanostructures offer precise control over size, shape, and programmability, ideal for biomedical applications.
• DNA nanostructures are increasingly explored for drug delivery systems (DDSs) due to their biocompatibility and versatility.

Purpose of the Study:

• To review recent advancements in DNA nanotechnology for nanomedicine.
• To highlight the application of DNA nanostructures in drug delivery systems (DDSs).
• To provide a perspective on future opportunities in DNA nanotechnology-enabled nanomedicine.

Main Methods:

• Literature review of recent research in DNA nanotechnology and nanomedicine.
• Analysis of studies focusing on DNA nanostructures for drug delivery.
• Synthesis of findings on the benefits and challenges of DNA-based DDSs.

Main Results:

• DNA nanostructures demonstrate significant potential in biosensing, bioimaging, and disease therapy.
• Multifunctional DNA-based DDSs show effectiveness in enhancing drug delivery and reducing systemic toxicity.
• The programmability and homology of DNA enable sophisticated and intelligent drug carriers.

Conclusions:

• DNA nanotechnology is a rapidly advancing field with transformative potential in nanomedicine.
• DNA-based drug delivery systems offer unique advantages over traditional methods.
• Future research should focus on further optimizing DNA nanostructures for clinical translation and therapeutic efficacy.